Anastasiya S. Artemova

Anastasiya S. Artemova

Auto-generated profile, based on publicly available information

Anastasiya S. Artemova

Almazov National Medical Research Center

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Open access
PDF file
NGNikolay I. Glushkov
Nikolay I. Glushkov
MIMichael A. Ivanov
Michael A. Ivanov
PPPetr D. Puzdryak
Petr D. Puzdryak
KSKristina V. Samko
Kristina V. Samko
AIAlina A. Isakova
Alina A. Isakova
AAAnastasia S. Artemova
Anastasia S. Artemova
The purpose of this study was to assess the effect of metabolic disorders on the effects of revascularization in patients with obliterating atherosclerosis. Materials and methods. The reconstruction was performed in 253 patients with femoral-tibial arterial segment lesion (98 open operations, 116 endovascular interventions and 39 patients were treated with hybrid technique). Results. Endovascular revascularization techniques are justified in case of disorders of carbohydrate metabolism. Conventional operations remain the method of choice in the case of those variants of atherosclerotic lesions, where minimally invasive techniques are impossible. Conclusions. Metabolic disorders in patients with peripheral atherosclerosis on the background of severe comorbid pathology may be the basis for choosing hybrid methods of revascularization.

15 April 2023 in The Clinician
Verified
Journal Article
Open access
PDF file
SMS. M. Markin
S. M. Markin
SGS. V. Grishin
S. V. Grishin
AAA. S. Artemova
A. S. Artemova
The era of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus has shown that non-core specialists can be involved in the treatment of epidemic diseases. However, the entire burden for the prevention and treatment of venous thromboembolism (VTE) falls on doctors – cardiovascular surgeons, phlebologists. It should be borne in mind that most of the thromboses – more than 2 million cases per year – are asymptomatic, and only a small part has pulmonary embolism, pulmonary hypertension, and death. The survival rate of patients with deep vein thrombosis (DVT) for 8 years is 65 %, with a combination of DVT with pulmonary embolism; the survival rate does not exceed 34 %, so a doctor of any specialty should know how to suspect VTE. The clinical picture of DVT is not always pronounced. Most often, with DVT, patients complain of swelling and pain in the affected lower limb, a decrease in the volume of active movements, and skin cyanosis. Diagnosis of DVT and thromboembolic complications at the non-specialized level should initially consist of assessing the risk of VTE using special scales, among which the Wales scale is of the greatest importance. The gold standard for diagnosing DVT is duplex ultrasound. Among the main indicators for hospitalization is not the fact of the established diagnosis of DVT, but the presence of comorbid pathology, chronic lung diseases, and old age. Additional risk factors include extended DVT, suspected pulmonary embolism, and pregnancy. The goal of anticoagulant therapy is to stop the process of pathological hypercoagulability, the progression of thrombus formation and create conditions for restoring vascular patency, while the pathological idea is that anticoagulants “dissolve the thrombus”. In this regard, anticoagulant therapy is the mainstay of treatment for DVT. To determine the duration of anticoagulant therapy, the etiology of thrombosis is of particular importance – the trigger that led to the formation of thrombotic masses.

27 March 2025 in Journal of Venous Disorders
Verified
Journal Article
Closed access
EGE.K. Gavrilov
E.K. Gavrilov
RAR.A. Akhadov
R.A. Akhadov
AAA.S. Artemova
A.S. Artemova
EBE.A. Babinets
E.A. Babinets
GKG.G. Khubulava
G.G. Khubulava
Objective. To study clinical and ultrasound semiotics of primary varicose vein recurrence after invasive treatment. Material and methods. We analyzed 64 consecutive patients with varicose vein recurrence after invasive treatment (crossectomy, stripping (35 patients) and thermal obliteration (27 patients)). Ehere were 21 men (32.8%) and 43 women (67.2%) (mean age 50.8±1.6). Recurrence variants and their combinations were analyzed. Reflux sources were recorded in accordance with the REVAS classification. We estimated time interval after surgery, period between surgery and recurrence, the number of invasive interventions, localization of recurrent varicose veins, including their relationship with sites of previous interventions, CEAP class. Results. The median period after invasive treatment was 53 months. Recurrence within the area of previous procedure was registered in 14 patients (21.9%), outside these areas — in 11 patients (17.2%). Combined localization was revealed in 39 patients (60.9%). Recurrence due to disease progression was detected in 11 patients (17.2%), residual veins — in 2 patients (3.1%), recurrent veins — in 3 patients (4.7%), combination — in 48 patients (75%). Neovascularization was detected in 11 patients (17.2%). One source of reflux out of seven possible according to the REVAS classification was detected only in 7 patients (10.9%). Other 57 (89.1%) ones had two or more sources. Trunk insufficiency was detected in 53 patients (82.8%). Incompetent segments of the main saphenous veins after open and endovenous procedures were detected in 11 and 24 patients, respectively (35%/54.7%). Insufficiency of veins that were intact before the first procedure was detected in 18 (28.1%) patients. When analyzing the subgroups after high ligation with stripping and thermal ablation, we found significant differences in time after the first procedure, localization of recurrent varicose veins, incidence of trunk incompetence and previous treatment mistakes. Conclusion. The structure of recurrences is similar after high ligation with stripping and thermal obliteration with phlebectomy. Differences in rates of certain recurrence are probably associated with tactical and technical features of two treatment approaches.

16 May 2024 in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
Verified
Journal Article
Open access
PDF file
VBVadim Yu Bogachev
Vadim Yu Bogachev
OAO. A. Alukhanyan
O. A. Alukhanyan
GVG. N. Vanyan
G. N. Vanyan
SMS. M. Markin
S. M. Markin
AAA. S. Artemova
A. S. Artemova
PKP. F. Kravtsov
P. F. Kravtsov
Introduction. Despite modern advances in technologies for the treatment and prevention of varicose veins, there is currently no radical treatment for varicose veins. The probability of recurrence of dilated veins, according to various authors, ranges from 5 to 70%. Along with the well-established concept of recurrence of varicose veins, the term progression of varicose veins is increasingly common in everyday life.Aim. To study the current understanding of the term relapse and the practical attitude of specialists involved in the treatment of varicose veins to it.Material and methods. In 2023, a survey of 117 specialists on the recurrence/progression of varicose veins was conducted. The respondents were doctors involved in the treatment of varicose veins: vascular surgeons 22.4%, phlebologists 50%, general surgeons 19.8%, specialists in ultrasound/functional diagnostics 7.8%, X-ray endovascular surgeon 0.85%. The questionnaire included 18 questions regarding the frequency of visits of patients with relapse/progression of varicose veins; views on tactics, as well as the attitude of specialists to the issue of progression and recurrence of varicose veins in patients after its surgical treatment.Results and discussion. The concept of recurrence and progression of varicose veins among specialists dealing with this pathology is not always comparable. There are differences in views both on the predisposing factors for the recurrence of dilated veins, and, accordingly, on the tactics of treatment and preventive measures. In some cases, according to statistics, they are due to specialization.Conclusions. The incidence of relapse and progression at the reception of the respondents has a slight difference. Despite the fact that there are opinions that do not correspond to generally accepted and abhorrent collegiality, mostly specialists try to separate these concepts, see differences in provoking factors and, accordingly, in recommendations.

15 May 2023 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
AAA. S. Artemova
A. S. Artemova
MCM. A. Chernyavskiy
M. A. Chernyavskiy
BACKGROUND: the effect of diabetes mellitus on the long-term patency of autovenous femoro-popliteal bypass has not been definitively determined AIM: to determine the effect of diabetes mellitus on the long-term outcomes of autovenous femoral-popliteal bypass.MATERIALS AND METHODS: the results of treatment of 648 patients who underwent autovenous femoral-popliteal bypass were analyzed. The patients were divided into 2 clinical groups: the first group included 367 patients with diabetes mellitus, the second — 281 patients without the named disease. The groups did not differ significantly in the incidence of concomitant pathology.RESULTS: occlusion of the autovenous conduit within a 5-year period after surgical treatment was observed in 218 patients of the first group (59.4%) and 72 patients of the second group (25.6%) (p <0.01, χ2 = 39.05, RR = 1.78; CI = 1.53–2.12). The average service life of the autovenous femoral-popliteal bypass was 63.49 months in patients of the first group, and 107.46 months in the second. The decompensated course of diabetes mellitus was observed in 203 patients (55.2%). Among patients with decompensated diabetes mellitus, occlusion of the autovenous femoral-popliteal bypass was observed in 95 patients (46.8%), in 104 patients the autovenous conduit was passable (51.2%; p = 0.449, χ2 = 0.57). Decompensated course of diabetes mellitus may contribute to a decrease in the service life of autovenous femoro-popliteal bypass.CONCLUSION: the presence of diabetes mellitus, and especially its decompensated course, can negatively affect the patency of autovenous femoro-popliteal bypass in the long term.

23 April 2023 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
AAA.S. Artemova
A.S. Artemova
NSN.V. Susanin
N.V. Susanin
AVA.G. Vanyurkin
A.G. Vanyurkin
MCM.A. Chernyavsky
M.A. Chernyavsky
Objective. To compare the results of endovascular interventions in patients with chronic lower limb ischemia following occlusion of autovenous femoropopliteal bypass grafts. Material and methods. There were 86 patients divided into 3 clinical groups in accordance with repeated arterial reconstruction: 62 patients underwent revascularization, balloon angioplasty with stenting of superficial femoral artery (group 1); 14 patients underwent balloon angioplasty with deep femoral artery stenting (group 2); 10 patients underwent revascularization, balloon angioplasty with stenting of autovenous femoropopliteal bypass graft (group 3). All groups did not differ in age and gender of patients. Results. Mean time of endovascular intervention was 65±16 min. At the first year after surgery, thrombosis of reconstruction area occurred in 11 (12.8%) patients, and false aneurysms after arterial puncture arose in 7 (8.1%) cases (inguinal access — 4 cases, popliteal artery puncture — 3 cases). One (1.2%) patient required amputation due to irreversible ischemia. Conclusion. Endovascular treatment of patients with occlusion of autovenous femoropopliteal bypass grafts is characterized by favorable immediate results.